At­las Ven­ture vows to keep do­ing well by do­ing good with its new, $350M biotech fund

One of the most promi­nent biotech in­cu­ba­tors in the ven­ture busi­ness has launched a new $350 mil­lion fund to help fu­el a new wave of star­tups. At­las Ven­ture part­ners say that they plan to con­tin­ue to be guid­ed by their mot­to and mis­sion: do­ing well by do­ing good.

Based in Kendall Square, the group in­cludes some well-known vet­er­ans. They in­clude Jean-François Formela, Ja­son Rhodes, Bruce Booth, and David Grayzel. Kevin Bit­ter­man was re­cent­ly wooed in from Po­laris, an­oth­er start­up spe­cial­ist. And with the de­but of Fund XI, Pe­ter Bar­rett will tran­si­tion to a ven­ture part­ner role.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER